19th Annual Global CEO Survey: Pharmaceuticals and life sciences industry key findings

Mar 2016

Redefining business success in a changing world

87 pharmaceuticals and life sciences CEOs in 35 countries were interviewed for PwC’s 19th Annual Global CEO survey.

Pharmaceuticals and life sciences CEOs are optimistic about a future which will see continuing growth through innovative products and partnerships, but they recognise the challenge of realising their ambitions in a world where expectations are growing all the time. New technologies will help both to deliver life-saving innovation and to enrich engagement with stakeholders.

Key industry findings:

  • Pharmaceuticals and life sciences CEOs are optimistic about future prospects.
  • Over-regulation and exchange rate volatility are top of pharma CEOs' list of threats to growth.
  • CRM and R&D technologies are viewed by pharma CEOs as key to increasing stakeholder engagement.

Contact us

Mark Gilbraith
China & Hong Kong Management Consulting Leader, Health Industries Leader and Consumer & TMT Consulting Leader
Tel: +[86] (21) 2323 2898

Follow us